Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-69

capitulation is an easier concept to suggest than to achieve. I’m pretty confident that there are thousands of far more capable investment minds than my own and maybe they’re pretty good at spotting capitulations? I don’t have a clue? I do have a lot of other things and sometimes I’m just happy to pick up some things where and when they turn up. Consistently buying somewhere low and selling somewhere higher is a better strategy than hoping to pick the absolutes of share price movements. I’ve only ever bought at the absolute bottom ONCE in my life.

as for margins… the device will be close to break even so maybe the 16% was about manufacturing margins? The SaaS margins, as you clearly are aware of, are likely to be significant. 40% might be net margin after all the costs? It does look like HeraCARE can and will scale quickly so those costs average down very quickly. If it all goes to plan, it’s a compelling story. Particularly given how much systems need to change in the first place, it really renders the next mover with a HUGE deficit just to get their ball rolling…. HeraCARE is a game winning move, HeraBEAT is a super cool thing.

just my random musings.. my finances aren’t dependent on this going well and I will comfortably survive if it fails so be mindful of your own position when you start to get into the conviction mindset.